Cash flow Dr. Lal PathLabs Limited

Equities

LALPATHLAB

INE600L01024

Healthcare Facilities & Services

Delayed NSE India S.E. Other stock markets 05:02:42 2024-09-18 am EDT			5-day change	1st Jan Change
3,219.40 ^INR	-1.95%		-4.68%	+24.94%

Aug. 12	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR3,720 From INR2,713, Keeps at Buy	MT
Aug. 08	Dr. Lal PathLabs' Consolidated Net Profit Shows Growth in Fiscal Q1	MT

72e86ecd.p1QktgjVTSJAKobF9RFdfRbsnUnPRTktqytw_T0OFL0.lmIT-EnnAGQoHvC2lGALSSKDrRiVBA5A-2xArW9gUMuRNRzwUYoeGid47Q

Published financial data: DR. LAL PATHLABS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2020	2021	2022	2023	2024
Revenues	13.3B	15.81B	20.87B	20.17B	22.27B
Other Revenues, Total	-	-	-	-	-
Total Revenues	13.3B	15.81B	20.87B	20.17B	22.27B
Cost of Goods Sold, Total	5.73B	7.05B	9.2B	8.92B	9.48B
Gross Profit	7.58B	8.77B	11.68B	11.25B	12.79B
Selling General & Admin Expenses, Total	2.22B	2.5B	3.47B	3.58B	4.14B
Provision for Bad Debts	-	-	6.16M	36.47M	-
R&D Expenses	-	-	-	-	-
Depreciation & Amortization - (IS)	728M	772M	1.08B	1.5B	1.44B
Other Operating Expenses	1.92B	1.9B	2.57B	2.73B	2.54B
Other Operating Expenses, Total	4.87B	5.17B	7.13B	7.85B	8.11B
Operating Income	2.71B	3.6B	4.55B	3.4B	4.68B
Interest Expense, Total	-153M	-160M	-302M	-375M	-294M
Interest And Investment Income	456M	439M	473M	332M	554M
Net Interest Expenses	303M	279M	171M	-43.52M	261M
Currency Exchange Gains (Loss)	-	-	-	-	-
Other Non Operating Income (Expenses)	3.37M	16.52M	1.27M	1.02M	1.24M
EBT, Excl. Unusual Items	3.02B	3.89B	4.72B	3.36B	4.94B
Gain (Loss) On Sale Of Investments	83.15M	47.29M	31.62M	64.21M	104M
Gain (Loss) On Sale Of Assets	1.49M	-1.74M	-6M	8.07M	-2.18M
Other Unusual Items	5.31M	5.42M	4.95M	6.96M	9.29M
EBT, Incl. Unusual Items	3.11B	3.94B	4.75B	3.44B	5.05B
Income Tax Expense	829M	979M	1.25B	1.03B	1.43B
Earnings From Continuing Operations	2.28B	2.96B	3.5B	2.41B	3.62B
Net Income to Company	2.28B	2.96B	3.5B	2.41B	3.62B
Minority Interest	-16.46M	-48.58M	-54.58M	-22.29M	-45.58M
Net Income - (IS)	2.26B	2.92B	3.45B	2.39B	3.58B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	2.26B	2.92B	3.45B	2.39B	3.58B
Net Income to Common Excl. Extra Items	2.26B	2.92B	3.45B	2.39B	3.58B
Per Share Items
Net EPS - Basic	27.42	35.33	41.7	28.82	43.05
Basic EPS - Continuing Operations	27.42	35.33	41.7	28.82	43.05
Basic Weighted Average Shares Outstanding	82.4M	82.54M	82.69M	82.86M	83.11M
Net EPS - Diluted	27.37	35.25	41.57	28.74	42.98
Diluted EPS - Continuing Operations	27.37	35.25	41.57	28.74	42.98
Diluted Weighted Average Shares Outstanding	82.55M	82.74M	82.94M	83.12M	83.24M
Normalized Basic EPS	22.67	28.89	35.01	25.07	36.63
Normalized Diluted EPS	22.63	28.82	34.9	24.99	36.57
Dividend Per Share	12	20	12	12	24
Payout Ratio	56.53	33.98	33.83	43.13	55.76
Supplemental Items
EBITDA	3.08B	3.99B	5.19B	4.41B	5.67B
EBITA	2.72B	3.62B	4.78B	3.93B	5.21B
EBIT	2.71B	3.6B	4.55B	3.4B	4.68B
EBITDAR	3.23B	4.14B	5.45B	4.66B	5.94B
Total Revenues (As Reported)	13.85B	16.33B	21.4B	20.59B	22.96B
Effective Tax Rate - (Ratio)	26.7	24.83	26.25	29.88	28.32
Total Current Taxes	838M	1.02B	1.26B	1.08B	1.48B
Total Deferred Taxes	-8.96M	-41.84M	-17.88M	-51.41M	-48.67M
Normalized Net Income	1.87B	2.38B	2.89B	2.08B	3.04B
Interest on Long-Term Debt	150M	156M	199M	223M	200M
Non-Cash Pension Expense	5.02M	4.57M	4.65M	9.9M	13.74M
Supplemental Operating Expense Items
Advertising Expense	342M	307M	368M	508M	733M
Selling and Marketing Expenses	342M	307M	368M	508M	733M
General and Administrative Expenses	1.73B	2.04B	2.85B	2.82B	3.13B
Research And Development Expense From Footnotes	-	-	-	-	-
Net Rental Expense, Total	151M	148M	261M	249M	272M
Imputed Operating Lease Interest Expense	-	136M	184M	157M	192M
Imputed Operating Lease Depreciation	-	12.69M	76.41M	91.94M	80.19M
Maintenance & Repair Expenses, Total	315M	338M	526M	683M	716M
Stock-Based Comp., COGS (Total)	166M	204M	323M	228M	217M
Total Stock-Based Compensation	166M	204M	323M	228M	217M

Fiscal Period: March	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.97B	2.44B	3.78B	2.64B	3.61B
Short Term Investments	3.71B	6.8B	2.38B	4.01B	4.68B
Trading Asset Securities, Total	1.64B	593M	655M	1.5B	1.14B
Total Cash And Short Term Investments	7.32B	9.84B	6.82B	8.14B	9.43B
Accounts Receivable, Total	514M	667M	854M	708M	774M
Other Receivables	203M	236M	199M	216M	315M
Notes Receivable	9.06M	9.31M	10.68M	13.64M	12.77M
Total Receivables	726M	912M	1.06B	938M	1.1B
Inventory	570M	426M	525M	338M	373M
Prepaid Expenses	92.71M	81.69M	139M	128M	164M
Restricted Cash	1.44M	1.43M	1.43M	-	-
Other Current Assets, Total	220M	191M	205M	184M	202M
Total Current Assets	8.93B	11.45B	8.75B	9.73B	11.27B
Gross Property Plant And Equipment	4.37B	5.13B	-	7.79B	7.95B
Accumulated Depreciation	-1.35B	-2.01B	-	-3.75B	-4.48B
Net Property Plant And Equipment	3.02B	3.12B	4.3B	4.04B	3.47B
Long-term Investments	-	-	-	-	-
Goodwill	772M	854M	5.5B	5.48B	5.48B
Other Intangibles, Total	451M	595M	4.11B	3.58B	3.04B
Loans Receivable Long-Term	260K	700K	1.07M	560K	320K
Deferred Tax Assets Long-Term	228M	280M	370M	404M	449M
Other Long-Term Assets, Total	344M	312M	506M	620M	849M
Total Assets	13.74B	16.61B	23.53B	23.86B	24.56B
Liabilities
Accounts Payable, Total	1.18B	1.44B	1.47B	1.56B	1.87B
Accrued Expenses, Total	215M	229M	410M	405M	503M
Short-term Borrowings	-	-	954M	700M	-
Current Portion of Long-Term Debt	-	-	834M	833M	833M
Current Portion of Leases	364M	402M	481M	528M	606M
Current Income Taxes Payable	1.89M	49.44M	31.56M	4.97M	133M
Unearned Revenue Current, Total	15.06M	95.46M	94.92M	97.19M	117M
Other Current Liabilities	500M	526M	721M	567M	595M
Total Current Liabilities	2.27B	2.74B	5B	4.7B	4.65B
Long-Term Debt	-	1.19M	1.67B	833M	-
Long-Term Leases	930M	1.1B	1.39B	1.3B	1.03B
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	-	7.55M	40.39M	29.41M	23.92M
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	3.2B	3.85B	8.1B	6.86B	5.71B
Preferred Stock Convertible	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	833M	833M	833M	834M	835M
Additional Paid In Capital	928M	928M	928M	935M	1.05B
Retained Earnings	8.51B	10.52B	12.93B	14.53B	16.34B
Treasury Stock	-241M	-200M	-162M	-119M	-144M
Comprehensive Income and Other	301M	369M	554M	482M	410M
Total Common Equity	10.33B	12.45B	15.08B	16.66B	18.49B
Minority Interest	212M	310M	355M	332M	361M
Total Equity	10.54B	12.76B	15.44B	17B	18.85B
Total Liabilities And Equity	13.74B	16.61B	23.53B	23.86B	24.56B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	82.48M	82.62M	82.76M	82.94M	83.21M
ECS Total Common Shares Outstanding	82.48M	82.62M	82.76M	82.94M	83.21M
Book Value / Share	125.23	150.69	182.22	200.9	222.23
Tangible Book Value	9.11B	11B	5.48B	7.6B	9.97B
Tangible Book Value Per Share	110.4	133.16	66.17	91.66	119.79
Total Debt	1.29B	1.5B	5.33B	4.19B	2.47B
Net Debt	-6.02B	-8.34B	-1.49B	-3.95B	-6.96B
Debt Equivalent of Unfunded Proj. Benefit Obligation	53.55M	54.45M	157M	188M	261M
Debt Equivalent Oper. Leases	1.21B	1.19B	2.08B	1.99B	2.17B
Minority Interest, Total (Incl. Fin. Div)	212M	310M	355M	332M	361M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Finished Goods, Total	-	-	-	-	-
Inventories - Others	570M	426M	525M	338M	373M
Land - (BS)	110M	110M	-	110M	110M
Buildings, Total	520M	524M	-	554M	555M
Machinery, Total	1.66B	1.96B	-	3.05B	3.29B
Full Time Employees	3.92K	4K	4.11K	4.05K	4.1K
Accumulated Allowance for Doubtful Accounts (Supple)	166M	215M	285M	345M	315M

Fiscal Period: March	2020	2021	2022	2023	2024
Net Income	2.26B	2.92B	3.45B	2.39B	3.58B
Depreciation & Amortization - CF	648M	676M	780M	898M	834M
Amortization of Goodwill and Intangible Assets - (CF)	14.45M	25.15M	228M	532M	533M
Depreciation & Amortization, Total	663M	701M	1.01B	1.43B	1.37B
Amortization of Deferred Charges, Total - (CF)	65.43M	70.73M	73.35M	72.26M	68.25M
(Gain) Loss From Sale Of Asset	-1.49M	1.74M	6M	-8.07M	2.18M
(Gain) Loss on Sale of Investments - (CF)	-83.15M	-47.29M	-31.62M	-64.21M	-104M
Stock-Based Compensation (CF)	166M	204M	323M	228M	217M
Provision and Write-off of Bad Debts	59.17M	51.26M	-6.96M	112M	7.18M
Other Operating Activities, Total	-411M	-283M	-186M	46.92M	-140M
Change In Accounts Receivable	-40.82M	-204M	-180M	33.35M	-72.96M
Change In Inventories	-284M	144M	-99.83M	187M	-35.01M
Change In Accounts Payable	381M	269M	34.33M	92.27M	305M
Change in Other Net Operating Assets	66M	158M	78.42M	41.78M	161M
Cash from Operations	2.84B	3.98B	4.47B	4.56B	5.35B
Capital Expenditure	-471M	-356M	-941M	-365M	-512M
Sale of Property, Plant, and Equipment	6.76M	4.16M	16.47M	5.03M	8.76M
Cash Acquisitions	-278M	-31.5M	-4.58B	-178M	-3.54M
Sale (Purchase) of Intangible assets	-325M	-240M	-3.82B	-80.51M	-62.67M
Investment in Marketable and Equity Securities, Total	398M	-1.89B	4.33B	-2.56B	-147M
Other Investing Activities, Total	408M	396M	496M	306M	473M
Cash from Investing	-261M	-2.12B	-4.49B	-2.87B	-243M
Long-Term Debt Issued, Total	-	-	3.45B	-	-
Total Debt Issued	-	-	3.45B	-	-
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-351M	-235M	-621M	-1.43B	-1.87B
Total Debt Repaid	-351M	-235M	-621M	-1.43B	-1.87B
Issuance of Common Stock	1.66M	1.49M	1.38M	8.72M	34.88M
Issuance of Preferred Stock	-	1.5M	-	-	-
Common Dividends Paid	-1.28B	-991M	-1.17B	-1.03B	-1.99B
Common & Preferred Stock Dividends Paid	-	-	-	-	-
Common & Preferred Stock Dividends Paid	-1.28B	-991M	-1.17B	-1.03B	-1.99B
Other Financing Activities, Total	-278M	-162M	-304M	-379M	-311M
Cash from Financing	-1.9B	-1.39B	1.36B	-2.83B	-4.14B
Miscellaneous Cash Flow Adjustments	-	-	-10K	-	-
Net Change in Cash	673M	476M	1.34B	-1.14B	972M
Supplemental Items
Cash Interest Paid	460K	158M	304M	377M	294M
Cash Income Tax Paid (Refund)	1.2B	1.02B	1.3B	1.06B	1.32B
Levered Free Cash Flow	2.01B	2.96B	-637M	3.43B	4.14B
Unlevered Free Cash Flow	2.11B	3.06B	-449M	3.66B	4.33B
Change In Net Working Capital	-317M	-429M	-66.53M	-252M	-324M
Net Debt Issued / Repaid	-351M	-235M	2.83B	-1.43B	-1.87B

Fiscal Period: March	2020	2021	2022	2023	2024
Profitability
Return on Assets	13.74	14.81	14.16	8.98	12.09
Return on Total Capital	15.87	17.23	16.23	10.15	13.76
Return On Equity %	22.7	25.45	24.85	14.9	20.21
Return on Common Equity	22.84	25.6	25.05	15.08	20.35
Margin Analysis
Gross Profit Margin %	56.94	55.43	55.94	55.78	57.44
SG&A Margin	16.7	15.8	16.64	17.74	18.57
EBITDA Margin %	23.12	25.22	24.86	21.88	25.48
EBITA Margin %	20.47	22.91	22.88	19.5	23.42
EBIT Margin %	20.36	22.75	21.78	16.87	21.02
Income From Continuing Operations Margin %